Press Releases Actavia Life Sciences, Inc.

Equities

RASP

US7538881068

Market Closed - OTC Markets Other stock markets 14:36:48 2024-05-10 EDT			5-day change	1st Jan Change
0.011 ^USD	-12.00%		-36.42%	+42.86%

02-16	Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
01-05	Actavia Life Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Actavia Life Sciences : Change in Certifying Accountants - Form 8-K	04-10	PU
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-03-02	AQ
RASNA THERAPEUTICS INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-02-09	AQ
Rasna Therapeutics : Certificate of Incorporation/Bylaws - Form 8-K	23-01-23	PU
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-01-23	AQ
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-12-20	AQ
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-22	AQ
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-06-21	AQ
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-06-16	AQ
Rasna Therapeutics : Amendment to Annual Report (Form 10-K/A)	22-06-10	PU
RASNA THERAPEUTICS INC. - 10-K/A - MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	22-06-10	AQ
Rasna Therapeutics : Unregistered Sales of Equity Securities - Form 8-K	22-05-24	PU
RASNA THERAPEUTICS INC. : Unregistered Sale of Equity Securities (form 8-K)	22-05-24	AQ
RASNA THERAPEUTICS INC. : Unregistered Sale of Equity Securities (form 8-K)	22-05-19	AQ
RASNA THERAPEUTICS INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	22-05-09	AQ
RASNA THERAPEUTICS INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-03-01	AQ
RASNA THERAPEUTICS INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	21-11-30	AQ
RASNA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21-08-16	AQ
RASNA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21-06-02	AQ
RASNA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21-04-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Actavia Life Sciences, Inc.

Equities

RASP

US7538881068

Press Releases

Filters